After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IMUX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Immunic Inc is $75.54M. A total of 2.45 million shares were traded on the day, compared to an average of 1.29M shares.
In the most recent transaction, Vitt Daniel bought 15,000 shares of IMUX for 0.77 per share on Jun 04 ’25. After the transaction, the CEO and Director now owns 29,000 company shares. In a previous transaction on Jun 04 ’25, Neermann Joerg bought 70,000 shares at 0.77 per share. IMUX shares that Director owns now total 170,000.
Among the insiders who bought shares, Neermann Joerg acquired of 30,000 shares on Jun 05 ’25 at a per-share price of $0.76. This resulted in the Director holding 200,000 shares of IMUX after the transaction. In another insider transaction, Whaley Glenn bought 45,000 shares at $0.71 per share on Jun 03 ’25. Company shares held by the Chief Financial Officer now total 95,510.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IMUX has a high of $2.11 and a low of $0.56.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IMUX’s latest balance sheet shows that the firm has $86.86M in Cash & Short Term Investments as of fiscal 2021. There were $992.00k in debt and $11.40M in liabilities at the time. Its Book Value Per Share was -$0.06, while its Total Shareholder’s Equity was $127.11M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMUX is Buy with a score of 5.00.
